What is the share price of Gujarat Terce Laboratories Ltd (GUJTERC) today?
The share price of GUJTERC as on 11th September 2026 is ₹41.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Gujarat Terce Laboratories Ltd (GUJTERC) share?
The past returns of Gujarat Terce Laboratories Ltd (GUJTERC) share are- Past 1 week: 1.22%
- Past 1 month: 12.22%
- Past 3 months: 32.46%
- Past 6 months: 6.30%
- Past 1 year: 3.65%
- Past 3 years: 97.43%
- Past 5 years: 176.67%
What are the peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC)?
The peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC) include:What is the market cap of Gujarat Terce Laboratories Ltd (GUJTERC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹29.31 Cr as of 11th September 2026.What is the 52 week high and low of Gujarat Terce Laboratories Ltd (GUJTERC) share?
The 52-week high of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹59.78 and the 52-week low is ₹29.What is the PE and PB ratio of Gujarat Terce Laboratories Ltd (GUJTERC) stock?
The P/E (price-to-earnings) ratio of Gujarat Terce Laboratories Ltd (GUJTERC) is 13.32. The P/B (price-to-book) ratio is 3.01.Which sector does Gujarat Terce Laboratories Ltd (GUJTERC) belong to?
Gujarat Terce Laboratories Ltd (GUJTERC) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Gujarat Terce Laboratories Ltd (GUJTERC) shares?
You can directly buy Gujarat Terce Laboratories Ltd (GUJTERC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Gujarat Terce Laboratories Ltd
GUJTERC Share Price
BSE₹41.501.22% (+0.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GUJTERC Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GUJTERC Performance & Key Metrics
GUJTERC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 14.23 | 3.01 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.35 | 5.84 | 0.49% |
GUJTERC Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GUJTERC Company Profile
Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.
SUNPHARMA
PE Ratio
39.76
39.76
1Y Return
14.31%
14.31%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
86.09
86.09
1Y Return
38.56%
38.56%
Buy Reco %
82.14
82.14
CIPLA
PE Ratio
29.83
29.83
1Y Return
12.48%
12.48%
Buy Reco %
62.86
62.86
ZYDUSLIFE
PE Ratio
22.17
22.17
1Y Return
7.23%
7.23%
Buy Reco %
57.69
57.69
LUPIN
PE Ratio
18.88
18.88
1Y Return
5.38%
5.38%
Buy Reco %
51.52
51.52
GUJTERC Forecast
GUJTERC Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GUJTERC
GUJTERC
Income
Balance Sheet
Cash Flow
Quarterly Normal View
GUJTERC Income Statement
GUJTERC Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12.29 | 11.96 | 13.38 | 12.75 | 12.41 | 10.95 | 12.98 | 12.42 | 11.48 | 9.48 | ||||||||||
Operating & Other expenses | 11.20 | 11.81 | 11.64 | 11.59 | 11.27 | 10.87 | 11.04 | 11.16 | 11.11 | 9.50 | ||||||||||
EBITDA | 1.09 | 0.15 | 1.74 | 1.16 | 1.14 | 0.08 | 1.94 | 1.26 | 0.37 | -0.02 | ||||||||||
| Depreciation/Amortization | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.13 | 0.11 | ||||||||||
| PBIT | 1.00 | 0.06 | 1.65 | 1.06 | 1.04 | -0.02 | 1.84 | 1.16 | 0.24 | -0.13 | ||||||||||
| Interest & Other Items | 0.15 | 0.13 | 0.13 | 0.08 | 0.07 | 0.05 | 0.07 | 0.04 | 0.03 | 0.03 | ||||||||||
| PBT | 0.85 | -0.07 | 1.52 | 0.98 | 0.97 | -0.07 | 1.77 | 1.12 | 0.21 | -0.16 | ||||||||||
| Taxes & Other Items | 0.30 | 0.01 | 0.03 | -0.03 | 4.36 | -0.03 | 0.38 | 0.37 | 0.10 | 0.03 | ||||||||||
| Net Income | 0.55 | -0.08 | 1.49 | 1.01 | -3.39 | -0.04 | 1.39 | 0.75 | 0.11 | -0.19 | ||||||||||
| EPS | 0.73 | -0.10 | 2.00 | 1.36 | -4.57 | -0.06 | 1.89 | 0.95 | 0.13 | -0.23 |
GUJTERC Company Updates
GUJTERC Stock Peers
GUJTERC Past Performance & Peer Comparison
GUJTERC Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Gujarat Terce Laboratories Ltd | 13.32 | 3.01 | — |
| Sun Pharmaceutical Industries Ltd | 39.76 | 5.44 | 0.84% |
| Torrent Pharmaceuticals Ltd | 86.09 | 10.59 | 0.69% |
| Cipla Ltd | 29.83 | 3.35 | 0.91% |
GUJTERC Stock Price Comparison
Compare GUJTERC with any stock or ETFCompare GUJTERC with any stock or ETF
GUJTERC
GUJTERC Holdings
GUJTERC Shareholdings
GUJTERC Promoter Holdings Trend
GUJTERC Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GUJTERC Institutional Holdings Trend
GUJTERC Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.08%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GUJTERC Shareholding Pattern
GUJTERC Shareholding Pattern
GUJTERC Shareholding History
GUJTERC Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing GUJTERC stock
smallcases containing GUJTERC stock
Looks like this stock is not in any smallcase yet.
GUJTERC Events
GUJTERC Events
GUJTERC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GUJTERC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GUJTERC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GUJTERC has not given any dividends in last 5 years
GUJTERC Dividends
GUJTERC Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGUJTERC Stock News & Opinions
GUJTERC Stock News & Opinions
Articles & Videos
Corporate
Corporate
Gujarat Terce Laboratories shareholders approved Aalap Prajapati’s three-year managing director tenureGujarat Terce Laboratories Limited clarified that the re-appointment of Mr. Aalap Prajapati as Managing Director & Chief Executive Officer will be for a period of three years, commencing from October 28, 2026, to October 27, 2029, correcting a previous announcement made on May 29, 2026, which incorrectly stated a five-year tenure. Shareholders approved the re-appointment at the company's 41st Annual General Meeting held on August 21, 2026.
3 weeks agoCapital Market - Live
Corporate
Corporate
Gujarat Terce Laboratories members re-appointed Aalap Prajapati as Managing Director & CEOGujarat Terce Laboratories Limited announced that its members approved the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for three years, effective October 28, 2026, to October 27, 2029, at the company's 41st Annual General Meeting held on August 21, 2026. Mr. Prajapati, who holds director identification number 08088327, has over 15 years of experience in the pharmaceutical sector and is the son of Whole-Time Director Mr. Natwarbhai Prajapati.
3 weeks agoCapital Market - Live
Corporate
Corporate
Gujarat Terce Laboratories to review quarterly results at a board meeting on August 7Gujarat Terce Laboratories Limited will hold a board meeting on Friday, August 7, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, which will be subject to limited review, the company said in a filing to the BSE Limited. The company’s trading window will be closed from Wednesday, July 1, 2026, to Saturday, August 9, 2026, for consideration of the financial results.
1 month agoCapital Market - Live
Corporate
Corporate
Gujarat Terce Laboratories AGM scheduledGujarat Terce Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 21 August 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Gujarat Terce Laboratories reports standalone net profit of Rs 0.10 crore in the March 2026 quarterNet profit of Gujarat Terce Laboratories reported to Rs 0.10 crore in the quarter ended March 2026 as against net loss of Rs 3.39 crore during the previous quarter ended March 2025. Sales declined 7.47% to Rs 11.40 crore in the quarter ended March 2026 as against Rs 12.32 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 2.20 crore in the year ended March 2026 as against net loss of Rs 0.98 crore during the previous year ended March 2025. Sales declined 5.44% to Rs 47.47 crore in the year ended March 2026 as against Rs 50.20 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales11.4012.32 -7 47.4750.20 -5 OPM %6.408.52 -7.887.73 - PBDT0.781.07 -27 3.903.77 3 PBT0.650.97 -33 3.483.39 3 NP0.10-3.39 LP 2.20-0.98 LP Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Gujarat Terce Laboratories announces board meeting dateGujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 27 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Gujarat Terce Laboratories standalone net profit declines 24.75% in the December 2025 quarterNet profit of Gujarat Terce Laboratories declined 24.75% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 1.01 crore during the previous quarter ended December 2024. Sales declined 3.08% to Rs 12.29 crore in the quarter ended December 2025 as against Rs 12.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales12.2912.68 -3 OPM %9.288.60 - PBDT1.231.08 14 PBT1.130.98 15 NP0.761.01 -25 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Gujarat Terce Laboratories schedules board meetingGujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
Gujarat Terce Laboratories standalone net profit declines 5.41% in the September 2025 quarterNet profit of Gujarat Terce Laboratories declined 5.41% to Rs 1.40 crore in the quarter ended September 2025 as against Rs 1.48 crore during the previous quarter ended September 2024. Sales declined 2.78% to Rs 12.93 crore in the quarter ended September 2025 as against Rs 13.30 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales12.9313.30 -3 OPM %14.6212.41 - PBDT1.881.60 18 PBT1.781.51 18 NP1.401.48 -5 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Gujarat Terce Laboratories to announce Quarterly ResultGujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.97%, vs industry avg of 11.79%
Over the last 5 years, market share stayed at 0.01%